Richard N Bergman

12PUBLICATIONS
12CO-AUTHORS
Veterinary pharmacologyMetabolic medicineAnimal growth and developmentEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 24, 2023
Dapagliflozin prevents abdominal visceral and subcutaneous adipose tissue dysfunction in the insulin-resistant canine model.

Morvarid Kabir, Richard N Bergman, Jay Porter

|Feb 15, 2022
The Physiology of Insulin Clearance.

Richard N Bergman, Morvarid Kabir, Marilyn Ader

|Jun 16, 2021
Hyperinsulinemic Compensation for Insulin Resistance Occurs Independent of Elevated Glycemia in Male Dogs.

Marilyn Ader, Richard N Bergman

|Sep 10, 2020
The Measurement of Insulin Clearance.

Francesca Piccinini, Richard N Bergman

|Aug 22, 2019
Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.

Richard N Bergman, Francesca Piccinini, Morvarid Kabir

|Dec 08, 2018
Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain.

Jarrad M Scarlett, Kenjiro Muta, Jenny M Brown

Pageof 2

Frequent Collaborators

2 joint publications

Marilyn Ader

2 joint publications

Morvarid Kabir

1 joint publications

Alena Stančáková

1 joint publications

Andreas Fritsche